SARASOTA, Fla., Oct. 18, 2024 (GLOBE NEWSWIRE) — Oragenics (NYSE:) Inc. (NYSE American: OGEN), a company focused on developing new treatments for brain-related conditions, announced that it will be present at Centurion One Capital’s Second Annual Bahamas Summit, which will be held at the Rosewood Baha Mar Hotel on February 22- October 23, 2024 in Nassau, Bahamas. Michael Redmond, President of Oragenics, will participate in a corporate presentation and Q&A session on October 22, 2024 at 1:20 PM ET.
The details of the presentation are as follows:
Date: Tuesday, October 22, 2024
Time: 1:20 PM EDT
Presenter: Michael Redmond, CEO of Oragenics
Register for the event by clicking here.
About Oragenics:
Oragenics is a development-stage biotechnology company focused on the intranasal delivery of pharmaceutical drugs for neurology and infectious diseases, including drug candidates for the treatment of mild traumatic brain injury (mTBI), also known as concussion, and for the treatment of Niemann Pick disease Type C (NPC). ), as well as a proprietary powder formula and device for intranasal administration. More information can be found at www.oragenics.com.
Investor relations:
Rich Cockrell
CG capital
404-736-3838
ogen@cg.capital
source: Oragenics
